Bd reports second quarter fiscal 2024 financial results

Margin execution drives better performance in quarter and higher guidance for fiscal 2024 q2 revenue of $5.0 billion increased 4.6% as reported, 4.7% currency-neutral and 5.7% organic q2 gaap and adjusted diluted eps of $1.85 and $3.17 grew 20.9% and 10.8%, respectively year-to-date cash from continuing operations of $1.4 billion and free cash flow of $1.1 billion increased $785 million and over $900 million, respectively company raises full-year adjusted eps guidance and affirms organic revenue growth guidance franklin lakes, n.j. , may 2, 2024 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced results for its second quarter of fiscal 2024, which ended march 31, 2024.
BDX Ratings Summary
BDX Quant Ranking